William A. Denny - Concepedia

Concepedia

Author

William A. Denny

University of Auckland

Also Known As

W A Denny, William A. Denny

21

Publications

1.6K

Citations

18

H-Index

25

Concepts

All Affiliations

University of Auckland Cancer Society of New Zealand

WA

About

William A. Denny is an author at University of Auckland specializing in natural sciences, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	404
2	Natural Sciences	4	4	263
3	Biochemistry	4	4	263
4	Engineering	1	1	59
5	Biomolecular Engineering	1	1	59

William A. Denny

×

18

Publications

1.6K

Citations

17

H-Index

	Year	Citations
Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor. Gordon W. Rewcastle, William A. Denny, Alexander J. Bridges, Journal of Medicinal Chemistry	1995	259
Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids Gordon W. Rewcastle, Graham J. Atwell, Li Zhuang, Journal of Medicinal Chemistry Implanted Colon 38Medicinal ChemistryBioorganic ChemistryPharmacological StudyBiochemistry	1991	194
DNA-intercalating ligands as anti-cancer drugs: prospects for future design. William A. Denny PubMed Dna NanotechnologyMedicinal ChemistryPolymer-drug ConjugateTopoisomerase IiMedicine	1989	162
Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as minimal DNA-intercalating antitumor agents with in vivo solid tumor activity Graham J. Atwell, Bruce C. Baguley, William A. Denny Journal of Medicinal Chemistry	1989	157
Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor Andrew M. Thompson, Alexander J. Bridges, David W. Fry, Journal of Medicinal Chemistry	1995	141
Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo Gordon W. Rewcastle, Graham J. Atwell, Bruce C. Baguley, Journal of Medicinal Chemistry	1989	114
Tyrosine Kinase Inhibitors. 4. Structure-Activity Relationships among N- and 3-Substituted 2,2'-Dithiobis(1H-indoles) for in vitro Inhibition of Receptor and Nonreceptor Protein Tyrosine Kinases Brian D. Palmer, Gordon W. Rewcastle, Andrew M. Thompson, Journal of Medicinal Chemistry	1995	75
Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells Brian D. Palmer, William R. Wilson, Stephen Cliffe, Journal of Medicinal Chemistry	1992	75
Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitizers Michael P. Hay, William R. Wilson, John W. Moselen, Journal of Medicinal Chemistry	1994	67
Evaluation of a crystalline nanosuspension: Polymorphism, process induced transformation and in vivo studies Puneet Sharma, Zoran Ẑujović, Graham A. Bowmaker, International Journal of Pharmaceutics NanoparticlesEngineeringVivo StudiesProtein NanoparticlesNanomaterials	2011	59

Page 1